Work

Antitumor Activities Of An Oral Selective HSP90α/β Inhibitor, TAS-116, In Combination With Bortezomib In Multiple Myeloma

Year: 2013

Type: article

Source: Blood

DOI: 10.1182/blood.v122.21.4429.4429

Authors: Rikio Suzuki, Teru Hideshima, Shuichi Ohkubo, Naoya Mimura, Jiro Minami, Hiroto Ohguchi, Shohei Kikuchi, Diana D. Cirstea, Francesca Cottini, Dharminder Chauhan, Paul G. Richardson, Nikhil C. Munshi, Teruhiro Utsugi, Kenneth C. Anderson

Institutions: Harvard University, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center, Taiho Pharmaceutical (Japan)

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2228141886

FWCI:

Cites:

Cited by:

Related to: 10